Table 4. Comparison between hematological parameters in CG, EG, AG, AG + A,D3,E, AOG, and OG.
| Parameter | CG (n = 20) | EG (n = 40) | TGs (n = 40) | |||
|---|---|---|---|---|---|---|
| AG (n = 10) | A + A,D3,E (n = 10) | AOG (n = 10) | OG (n = 10) | |||
| RBCs (×106/μl) | 12.59 ± 0.11f | 14.11 ± 0.08a | 12.94 ± 0.03b | 12.70 ± 0.07b,c | 12.77 ± 0.18b,c | 13.53 ± 0.09b,c,d,e |
| Hb (g/dl) | 14.18 ± 0.23f | 16.91 ± 0.08a | 14.86 ± 0.03b | 14.29 ± 0.11b,c | 14.44 ± 0.07b,c | 15.12 ± 0.07b,c,d,e |
| PCV (%) | 33.15 ± 0.81f | 38.31 ± 0.24a | 34.00 ± 1.49b | 33.40 ± 1.17b | 33.70 ± 1.06b | 35.50 ± 1.27b,c,d,e |
| MCV (fl) | 26.32 ± 0.62f | 27.15 ± 0.23a | 26.28 ± 1.19b | 26.30 ± 0.86b | 26.39 ± 0.96b | 26.25 ± 1.94b |
| MCH (pg) | 11.26 ± 0.23f | 11.98 ± 0.09a | 11.48 ± 0.04b | 11.25 ± 0.12b,c | 11.31 ± 0.20b,c | 11.18 ± 0.08b |
| MCHC (%) | 42.78 ± 1.08f | 44.13 ± 0.32a | 43.78 ± 1.92 | 42.84 ± 1.48b | 42.88 ± 1.34b | 42.65 ± 1.52b |
| TLC (×103/μl) | 7.21 ± 0.13f | 11.19 ± 0.19a | 7.78 ± 0.41b | 7.81 ± 0.17b | 7.85 ± 0.15b | 8.23 ± 0.40b,c,d,e |
| N (×103/μl) | 2.15 ± 0.02f | 7.14 ± 0.03a | 3.15 ± 0.32b | 2.95 ± 0.03b,c | 2.96 ± 0.04b,c | 3.75 ± 0.32b,c,d,e |
| L (×103/μl) | 4.06 ± 0.07f | 3.09 ± 0.06a | 3.65 ± 0.03b | 3.89 ± 0.06b,c | 3.92 ± 0.05b,c | 3.50 ± 0.04b,c,d,e |
| M (×103/μl) | 0.44 ± 0.07 | 0.43 ± 0.07 | 0.41 ± 0.06 | 0.41 ± 0.06 | 0.41 ± 0.06 | 0.41 ± 0.06 |
| E (×103/μl) | 0.53 ± 0.07 | 0.50 ± 0.09 | 0.52 ± 0.08 | 0.52 ± 0.08 | 0.52 ± 0.08 | 0.52 ± 0.08 |
| B (×103/μl) | 0.04 ± 0.05 | 0.04 ± 0.04 | 0.04 ± 0.05 | 0.04 ± 0.05 | 0.04 ± 0.05 | 0.04 ± 0.05 |
Values are means ± SD.
a
Significant with CG.
b
Significant with EG.
c
Significant with AG.
d
Significant with AG + A,D3,E.
e
Significant with AOG.
f
Significant between studied groups, considered significant when p < 0.05.